Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?5.0 WB, SLActive? 10mm, RXD: medical device reports filed with FDA

4,578 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

4,578
device reports naming the brand
0% of all MAUDE reports · about 679 a year
1,098
reports, 12 months to August 2026
1,036 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 4,578 reports that name the brand "BLX ?5.0 WB, SLActive? 10mm, RXD" (endosseous dental implant), received between October 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

1,098 reports arrived in the 12 months to August 2026, close to the 1,036 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (59.5%), loss of osseointegration (20.4%) and difficult to insert (1.9%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0115230Sep 2021: 25Oct 2021: 43Nov 2021: 34Dec 2021: 432022Jan 2022: 40Feb 2022: 41Mar 2022: 27Apr 2022: 32May 2022: 44Jun 2022: 60Jul 2022: 38Aug 2022: 51Sep 2022: 39Oct 2022: 56Nov 2022: 53Dec 2022: 572023Jan 2023: 47Feb 2023: 56Mar 2023: 56Apr 2023: 62May 2023: 91Jun 2023: 61Jul 2023: 45Aug 2023: 60Sep 2023: 82Oct 2023: 84Nov 2023: 69Dec 2023: 752024Jan 2024: 61Feb 2024: 57Mar 2024: 56Apr 2024: 110May 2024: 70Jun 2024: 79Jul 2024: 76Aug 2024: 95Sep 2024: 109Oct 2024: 101Nov 2024: 83Dec 2024: 902025Jan 2025: 77Feb 2025: 59Mar 2025: 76Apr 2025: 59May 2025: 0Jun 2025: 230Jul 2025: 67Aug 2025: 85Sep 2025: 85Oct 2025: 88Nov 2025: 74Dec 2025: 882026Jan 2026: 67Feb 2026: 71Mar 2026: 106Apr 2026: 96May 2026: 105Jun 2026: 113Jul 2026: 102Aug 2026: 103

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04949882019: 1320192020: 16420202021: 33720212022: 53820222023: 78820232024: 98720242025: 98820252026: 7632026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,578
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report67.5%3,090
Voluntary report0%0
User facility report0%0
Distributor report32.5%1,488
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,72359.5%62.8%
Loss of osseointegration93220.4%22.4%
Difficult to insertthe device was hard to insert881.9%0.4%
Fracturea broken bone230.5%1.6%
Separation failure130.3%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,66136.3%
Painpain, site not specified88019.2%
Inflammationinflammation2445.3%
Swelling/ edema1673.6%
Hemorrhage/blood loss/bleeding1513.3%
Hyperresponsive to stimuli1373%
Abscessa collection of pus1042.3%
Tissue damage791.7%
Hypersensitivity/allergic reaction420.9%
Fistula390.9%
Sinus perforation280.6%
Numbnessnumbness200.4%
Failure of implant150.3%
Increased sensitivity40.1%
Inadequate osseointegration30.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?5.0 WB, SLActive? 10mm, RXDProduct code DZEAll MAUDE reports
Reports4,5783,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer67.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?5.0 WB, SLActive? 10mm, RXD reports

How many FDA reports name BLX ?5.0 WB, SLActive? 10mm, RXD?

4,578 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,098 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (59.5%), loss of osseointegration (20.4%), difficult to insert (1.9%), fracture (0.5%) and separation failure (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (67.5%) and distributor reports (32.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?5.0 WB, SLActive? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.